Bortezomib

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12134 publications

Patterns of care in relapsed/refractory multiple myeloma in China: a real-world physician survey study.

Patterns of care in relapsed/refractory multiple myeloma in China: a real-world physician survey study.

Journal: Future oncology (London, England)

Published: April 13, 2026

Mesenteric AL Amyloidosis with Diffuse Calcifications: A Case Report and Review of the Literature.

Mesenteric AL Amyloidosis with Diffuse Calcifications: A Case Report and Review of the Literature.

Journal: Internal medicine (Tokyo, Japan)

Published: April 08, 2026

Phase separation of C19orf12 regulates BNIP3 protein quality control and maintains neuronal mitophagy.

Phase separation of C19orf12 regulates BNIP3 protein quality control and maintains neuronal mitophagy.

Journal: Autophagy

Published: April 06, 2026

Clinicopathological Characteristics of IgG4-Related Disease Involving Uterus and Abdominopelvic Lymph Nodes: A Case Report.

Clinicopathological Characteristics of IgG4-Related Disease Involving Uterus and Abdominopelvic Lymph Nodes: A Case Report.

Journal: International journal of surgical pathology

Published: April 01, 2026

Scleredema of Buschke: 2 cases with a remarkable response to treatment of the underlying paraprotein.

Scleredema of Buschke: 2 cases with a remarkable response to treatment of the underlying paraprotein.

Journal: JAAD case reports

Published: March 30, 2026

A rare case of renal cancer with PLA2R-positive membranous nephropathy and AL amyloidosis: Insights into mechanisms and treatment.

A rare case of renal cancer with PLA2R-positive membranous nephropathy and AL amyloidosis: Insights into mechanisms and treatment.

Journal: Clinical nephrology

Published: March 25, 2026

The Clinical Value of Plasma cfTFEB and miR-1246 in Predicting the Efficacy of Bortezomib Treatment for Patients with Multiple Myeloma

The Clinical Value of Plasma cfTFEB and miR-1246 in Predicting the Efficacy of Bortezomib Treatment for Patients with Multiple Myeloma

Journal: Zhongguo shi yan xue ye xue za zhi

Published: March 18, 2026

Clinical Study on the Transition of First-Line Bortezomib Intole- rance to Carfilzomib in the Treatment of Multiple Myeloma

Clinical Study on the Transition of First-Line Bortezomib Intole- rance to Carfilzomib in the Treatment of Multiple Myeloma

Journal: Zhongguo shi yan xue ye xue za zhi

Published: March 18, 2026

Proteasome Inhibition as a Cancer Type-Specific Off-Target Effect of Everolimus in Cancer Cells.

Proteasome Inhibition as a Cancer Type-Specific Off-Target Effect of Everolimus in Cancer Cells.

Journal: Biochemistry. Biokhimiia

Published: March 17, 2026

Bortezomib Induces Apoptosis via Upregulation of Abhd4 in Peripheral Nerve Cells.

Bortezomib Induces Apoptosis via Upregulation of Abhd4 in Peripheral Nerve Cells.

Journal: Biological & pharmaceutical bulletin

Published: March 15, 2026

Correction: TRIP13 alters mitochondrial function and promotes bortezomib resistance in multiple myeloma.

Correction: TRIP13 alters mitochondrial function and promotes bortezomib resistance in multiple myeloma.

Journal: Scientific reports

Published: March 13, 2026

Developing a Metabolic-Associated Prognostic Index for Risk Stratification and Therapeutic Guidance in Stage I Lung Adenocarcinoma via Multiomics Analysis.

Developing a Metabolic-Associated Prognostic Index for Risk Stratification and Therapeutic Guidance in Stage I Lung Adenocarcinoma via Multiomics Analysis.

Journal: JCO precision oncology

Published: March 02, 2026

Showing 1-12 of 12,134

Last Updated: 04/28/2026